157 related articles for article (PubMed ID: 18609506)
1. Vascular endothelial growth factor in dialysate in relation to intensity of peritoneal inflammation.
Pawlaczyk K; Polubinska A; Numata N; Nakayama M; Pecoits-Filho R; Czekalski S; Lindholm B; Breborowicz A
Int J Artif Organs; 2008 Jun; 31(6):535-44. PubMed ID: 18609506
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats.
Breborowicz A; Polubinska A; Moberly J; Ogle K; Martis L; Oreopoulos D
Am J Kidney Dis; 2001 Mar; 37(3):594-600. PubMed ID: 11228185
[TBL] [Abstract][Full Text] [Related]
3. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
[TBL] [Abstract][Full Text] [Related]
4. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
5. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
6. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.
Pecoits-Filho R; Carvalho MJ; Stenvinkel P; Lindholm B; Heimbürger O
Perit Dial Int; 2006; 26(1):53-63. PubMed ID: 16538876
[TBL] [Abstract][Full Text] [Related]
7. L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats.
Korybalska K; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Moberly J; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2002; 22(3):293-300. PubMed ID: 12227385
[TBL] [Abstract][Full Text] [Related]
8. Acute peritonitis in a C57BL/6 mouse model of peritoneal dialysis.
Leypoldt JK; Kamerath CD; Gilson JF
Adv Perit Dial; 2007; 23():66-70. PubMed ID: 17886606
[TBL] [Abstract][Full Text] [Related]
9. N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats.
Breborowicz A; Połubinska A; Wu G; Tam P; Oreopoulos DG
Blood Purif; 2006; 24(3):274-81. PubMed ID: 16465047
[TBL] [Abstract][Full Text] [Related]
10. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study.
Yang X; Zhang H; Hang Y; Yan H; Lin A; Huang J; Ni Z; Qian J; Fang W
Am J Nephrol; 2014; 39(6):459-65. PubMed ID: 24854010
[TBL] [Abstract][Full Text] [Related]
12. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate.
Pecoits-Filho R; Araújo MR; Lindholm B; Stenvinkel P; Abensur H; Romão JE; Marcondes M; De Oliveira AH; Noronha IL
Nephrol Dial Transplant; 2002 Aug; 17(8):1480-6. PubMed ID: 12147798
[TBL] [Abstract][Full Text] [Related]
13. A chronic inflammatory infusion model of peritoneal dialysis in rats.
Margetts PJ; Kolb M; Yu L; Hoff CM; Gauldie J
Perit Dial Int; 2001; 21 Suppl 3():S368-72. PubMed ID: 11887858
[TBL] [Abstract][Full Text] [Related]
14. Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients.
Cho Y; Johnson DW; Vesey DA; Hawley CM; Pascoe EM; Clarke M; Topley N;
BMC Nephrol; 2014 Jan; 15():8. PubMed ID: 24410736
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
[TBL] [Abstract][Full Text] [Related]
16. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal solute transport and inflammation.
Davies SJ
Am J Kidney Dis; 2014 Dec; 64(6):978-86. PubMed ID: 25176170
[TBL] [Abstract][Full Text] [Related]
18. The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammation.
Catar R; Witowski J; Wagner P; Annett Schramm I; Kawka E; Philippe A; Dragun D; Jörres A
Kidney Int; 2013 Dec; 84(6):1119-28. PubMed ID: 23760290
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
20. Dialysate cell-free mitochondrial DNA fragments as a marker of intraperitoneal inflammation and peritoneal solute transport rate in peritoneal dialysis.
Xie X; Wang J; Xiang S; Chen Z; Zhang X; Chen J
BMC Nephrol; 2019 Apr; 20(1):128. PubMed ID: 30975091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]